BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6712177)

  • 21. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
    Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
    Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
    Plowchalk DR; Mattison DR
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors.
    Huang Z; Waxman DJ
    Cancer Gene Ther; 2001 Jun; 8(6):450-8. PubMed ID: 11498765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
    Chen B; Cyr DG; Hales BF
    Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and binding of tritium from [chloroethyl 3H] cyclophosphamide by rat embryos in vitro.
    Mirkes PE; Greenaway JC
    Teratology; 1985 Jun; 31(3):373-80. PubMed ID: 4012646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stimulation of DNA synthesis in isolated nuclei of rat liver cells by neutral Mn-dependent DNase of chromatin].
    Vinter VG; Askarova AN; Zotkina NL; Khamidullina NG; Shliankevich MA
    Biokhimiia; 1988 Nov; 53(11):1906-11. PubMed ID: 3251555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of physiological concentrations of insulin and antidiabetic drugs on RNA release from isolated liver nuclei.
    Schumm DE; Webb TE
    J Cell Biochem; 1983; 23(1-4):223-9. PubMed ID: 6373797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
    Kwon CH; Maddison K; LoCastro L; Borch RF
    Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent binding of 2-acetylaminofluorene, 2-aminofluorene, and N-hydroxy-2-acetylaminofluorene to rat liver nuclear DNA and protein in vivo and in vitro.
    Stout DL; Hemminki K; Becker FF
    Cancer Res; 1980 Oct; 40(10):3579-84. PubMed ID: 7438044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
    Huang Z; Raychowdhury MK; Waxman DJ
    Cancer Gene Ther; 2000 Jul; 7(7):1034-42. PubMed ID: 10917206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteins recognized by antibodies against isolated cytological heterochromatin from rat liver cells change their localization between cell species and between stages of mitosis (interphase vs metaphase).
    Hara M; Igarashi J; Yamashita K; Iigo M; Yokosuka M; Ohtani-Kaneko R; Hirata K; Herbert DC
    Tissue Cell; 1999 Oct; 31(5):505-13. PubMed ID: 10612261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
    Cai Y; Wu MH; Ludeman SM; Grdina DJ; Dolan ME
    Cancer Res; 1999 Jul; 59(13):3059-63. PubMed ID: 10397244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline potentiates antitumor effect of cyclophosphamide in mice.
    Chhipa RR; Singh S; Surve SV; Vijayakumar MV; Bhat MK
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):268-77. PubMed ID: 15667832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hypoxia and limited diffusion in tumor cell microenvironment on bystander effect of P450 prodrug therapy.
    Günther M; Waxman DJ; Wagner E; Ogris M
    Cancer Gene Ther; 2006 Aug; 13(8):771-9. PubMed ID: 16543915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
    Hong PS; Chan KK
    Drug Metab Dispos; 1991; 19(3):568-73. PubMed ID: 1680621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.